文献速递神经核医学肿瘤 PET/CT

脑脊液蛋白通路改变与尾状核多巴胺转运体缺陷预测早期帕金森病认知脆弱性

CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson's disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-07-20

本研究基于帕金森病进展标志物计划,整合脑脊液蛋白组学、DAT-SPECT多巴胺转运体摄取与纵向认知评估,分析318例帕金森病患者和152例健康对照。结果显示早期帕金森病患者尾状核和壳核DAT摄取广泛降低,233种脑脊液蛋白差异表达;基线双侧尾状核DAT摄取降低与纵向认知轨迹不良及新发轻度认知障碍风险增加相关。

要点

  • 早期帕金森病患者尾状核、壳核和纹状体DAT摄取广泛降低。
  • 233种脑脊液蛋白差异表达,富集于突触信号、轴突导向和补体/凝血通路。
  • 基线双侧尾状核低DAT摄取预测纵向认知下降和新发轻度认知障碍风险增加。

核心结论

  • 尾状核多巴胺能功能障碍可能是早期帕金森病认知脆弱性的临床相关影像标志物。
  • 脑脊液蛋白通路改变为突触-轴突和免疫凝血变化提供分子背景,与认知脆弱性和部分认知轨迹相关。

研究设计与样本

  • 基于帕金森病进展标志物计划,整合脑脊液蛋白组学、DAT-SPECT摄取指标和纵向认知评估。
  • 横断面分析纳入318例帕金森病患者和152例健康对照,具有基线临床、DAT摄取和脑脊液蛋白组学数据。
  • 采用线性混合效应模型评估306例帕金森病患者0-5年认知轨迹,用Kaplan-Meier和Cox分析评估255例基线认知正常帕金森病患者的新发轻度认知障碍。

主要发现

  • 帕金森病患者在壳核、尾状核和纹状体显示DAT摄取广泛降低。
  • 233种脑脊液蛋白在帕金森病中差异表达,富集于神经元发育、突触信号、轴突导向、Wnt信号、谷氨酸能突触和补体/凝血通路。
  • 在帕金森病组内,神经脑脊液通路评分与双侧尾状核DAT摄取及HVLT辨别表现相关。
  • 基线双侧尾状核和纹状体DAT摄取较低预测多个认知域纵向认知轨迹较差,脑脊液通路评分与特定认知域变化相关。
  • 生存分析中,基线双侧尾状核低DAT摄取与新发轻度认知障碍风险增加相关。

临床怎么用

  • 在早期帕金森病中可关注基线双侧尾状核DAT摄取,作为认知脆弱性的影像参考指标。
  • 脑脊液蛋白通路改变可提供突触-轴突和免疫凝血相关的分子背景信息,辅助理解认知脆弱性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the relationships among CSF proteomic pathway alterations, dopamine transporter single-photon emission computed tomography (DAT-SPECT)-derived dopamine transporter uptake measures, and cognitive vulnerability, longitudinal cognitive decline, and incident mild cognitive impairment (MCI) in early PD. METHODS: We analyzed data from the Parkinson's Progression Markers Initiative, integrating CSF proteomics, DAT uptake measures, and longitudinal cognitive assessments. Cross-sectional analyses included 318 PD patients and 152 healthy controls with baseline clinical, DAT uptake, and CSF proteomic data. Linear mixed-effects models were used to evaluate 0-5-year cognitive trajectories in 306 PD patients, and Kaplan-Meier and Cox analyses assessed incident MCI in 255 cognitively normal PD patients at baseline. RESULTS: PD patients showed widespread reductions in DAT uptake across the putamen, caudate, and striatum. A total of 233 CSF proteins were differentially expressed in PD, with enrichment in neuronal development, synaptic signaling, axon guidance, Wnt signaling, glutamatergic synapse, and complement/coagulation pathways. Within PD, neural CSF pathway scores were associated with bilateral caudate DAT uptake and HVLT discrimination performance. Lower baseline bilateral caudate and striatal DAT uptake predicted less favorable longitudinal cognitive trajectories across multiple domains, while CSF pathway scores were associated with domain-specific cognitive changes. In survival analyses, low baseline bilateral caudate DAT uptake was associated with increased risk of incident MCI. CONCLUSIONS: These findings suggest that caudate dopaminergic dysfunction may serve as a clinically relevant imaging marker of cognitive vulnerability in early PD, whereas CSF proteomic pathway alterations provide molecular context for synaptic-axonal and immune-coagulation changes associated with cognitive vulnerability and selected cognitive trajectories.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ruan X, Huang X, Gong J, et al. CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson's disease. Eur J Nucl Med Mol Imaging. 2026. PMID: 42472725. doi:10.1007/s00259-026-08082-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。